Differential inhibition of cardiac and neuronal Na+ channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine
详细信息    查看全文
文摘
Duloxetine and venlafaxine are selective serotonin-norepinephrine-reuptake-inhibitors used as antidepressants and co-analgesics. While venlafaxine rather than duloxetine induce cardiovascular side-effects, neither of the substances are regarded cardiotoxic. Inhibition of cardiac Na+-channels can be associated with cardiotoxicity, and duloxetine was demonstrated to block neuronal Na+-channels. The aim of this study was to investigate if the non-life threatening cardiotoxicities of duloxetine and venlafaxine correlate with a weak inhibition of cardiac Na+-channels.

Effects of duloxetine, venlafaxine and amitriptyline were examined on endogenous Na+-channels in neuroblastoma ND7/23 cells and on the α-subunits Nav1.5, Nav1.7 and Nav1.8 with whole-cell patch clamp recordings.

Tonic block of the cardiac Na+-channel Nav1.5 and rat-cardiomyocytes (CM) revealed a higher potency for duloxetine (Nav 1.5 IC50 14±1 µM, CM IC50 27±3 µM) as compared to venlafaxine (Nav 1.5 IC50 671±26 µM, CM IC50 452±34 µM). Duloxetine was as potent as the cardiotoxic antidepressant amitriptyline (IC50 13±1 µM). While venlafaxine almost failed to induce use-dependent block on Nav1.5 and cardiomyocytes, low concentrations of duloxetine (1, 10 µM) induced prominent use-dependent block similar to amitriptyline. Duloxetine, but not venlafaxine stabilized fast and slow inactivation and delayed recovery from inactivation. Duloxetine induced an unselective inhibition of neuronal Na+-channels (IC50 ND7/23 23±1 µM, Nav1.7 19±2 µM, Nav1.8 29±2).

Duloxetine, but not venlafaxine inhibits cardiac Na+-channels with a potency similar to amitriptyline. These data indicate that an inhibition of Na+-channels does not predict a clinically relevant cardiotoxicity.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700